Results of initial operations in non-small cell lung cancer patients with single-level N2 disease

被引:28
作者
Ohta, Y [1 ]
Shimizu, Y [1 ]
Minato, H [1 ]
Matsumoto, I [1 ]
Oda, M [1 ]
Watanabe, G [1 ]
机构
[1] Kanazawa Univ, Sch Med, Dept Gen & Cardiothorac Surg, Kanazawa, Ishikawa 9208641, Japan
关键词
D O I
10.1016/j.athoracsur.2005.08.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. There is still debate regarding the use of surgery in the management of non-small cell lung cancer patients with N2 disease. The primary aim of the present study was analysis of the results of initial operations in non-small cell lung cancer patients with single-level N2 disease. Methods. Ninety-four patients with the disease who underwent initial surgery consisting of complete resection of the primary site plus systematic lymphadenectomy were examined. We also immunohistochemically examined lymphatic vessel density and vascular endothelial growth factor-C expression. Results. The overall 5- and 10-year survival rates for the 94 patients were 27.1% and 12.1%, respectively, with a median survival of 22 months. When stratified by skipping status, the 5-year survival rates for the patients in skip-N2 and non-skip-N2 groups were 33.4% and 19.8%, respectively (p = 0.0189). Skip metastasis, T factor, sub-carinal lymph node metastasis, and adjuvant chemotherapy were recognized as independent prognostic indicators. In both skip-N2 and non-skip-N2 groups, distant relapse was the dominant pattern of recurrence. Although the peritumoral lymphatic vessel density was associated with vascular endothelial growth factor-C expression in tumors, the lymphangiogenic profile appeared to be different between skip-N2 and non-skip-N2 tumors, suggesting different nodal metastatic process. Conclusions. Lung cancer patients with single-level N2 disease are an oncologically heterogeneous cohort. Although further studies involving randomized comparisons are required, the poor outcomes found here indicate that the initial operation has yet to be validated for patients with this disease.
引用
收藏
页码:427 / 433
页数:7
相关论文
共 32 条
[11]   PATTERNS OF MEDIASTINAL METASTASES IN BRONCHOGENIC-CARCINOMA [J].
LIBSHITZ, HI ;
MCKENNA, RJ ;
MOUNTAIN, CF .
CHEST, 1986, 90 (02) :229-232
[12]   Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer [J].
Liptay, MJ ;
Masters, GA ;
Winchester, DJ ;
Edelman, BL ;
Garrido, BJ ;
Hirschtritt, TR ;
Perlman, RM ;
Fry, WA .
ANNALS OF THORACIC SURGERY, 2000, 70 (02) :384-389
[13]   Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours [J].
Marks, A ;
Sutherland, DR ;
Bailey, D ;
Iglesias, J ;
Law, J ;
Lei, R ;
Yeger, H ;
Banerjee, D ;
Baumal, R .
BRITISH JOURNAL OF CANCER, 1999, 80 (3-4) :569-578
[14]   Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer [J].
Misthos, P ;
Sepsas, E ;
Athanassiadi, K ;
Kakaris, S ;
Skottis, I .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2004, 25 (04) :502-508
[15]   A novel method for sentinel lymph node mapping using magnetite in patients with non-small cell lung cancer [J].
Nakagawa, T ;
Minamiya, Y ;
Katayose, Y ;
Saito, H ;
Taguchi, K ;
Imano, H ;
Watanabe, H ;
Enomoto, K ;
Sageshima, M ;
Ueda, T ;
Ogawa, J .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 126 (02) :563-567
[16]  
NARUKE T, 1978, J THORAC CARDIOV SUR, V76, P832
[17]   Prognostic value of nonangiogenic and angiogenic growth patterns in non-small-cell lung cancer [J].
Nia, PS ;
Colpaert, C ;
Blyweert, B ;
Kui, B ;
Vermeulen, P ;
Ferguson, M ;
Hendriks, J ;
Weyler, J ;
Pezzella, F ;
Van Marck, E ;
Van Schil, P .
BRITISH JOURNAL OF CANCER, 2004, 91 (07) :1293-1300
[18]   VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane [J].
Oh, SJ ;
Jeltsch, MM ;
Birkenhager, R ;
McCarthy, JEG ;
Weich, HA ;
Christ, B ;
Alitalo, K ;
Wilting, J .
DEVELOPMENTAL BIOLOGY, 1997, 188 (01) :96-109
[19]   VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours [J].
Ohta, Y ;
Shridhar, V ;
Bright, RK ;
Kalemkerian, GP ;
Du, W ;
Carbone, M ;
Watanabe, Y ;
Pass, HI .
BRITISH JOURNAL OF CANCER, 1999, 81 (01) :54-61
[20]   Increased vascular endothelial growth factor and vascular endothelial growth factor-C and decreased NM23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer [J].
Ohta, Y ;
Nozawa, H ;
Tanaka, Y ;
Oda, M ;
Watanabe, Y .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2000, 119 (04) :804-813